Scientific American |
New Cholesterol Drug Lowers Risk of Heart Attack and Stroke
Scientific American … conference in Washington DC on March 17, show that a drug called evolocumab (Repatha) reduced the risk of cardiovascular death, heart attack and stroke by about 20% in patients who were already taking other cholesterol-controlling drugs called statins. Amgen’s Repatha lowers heart attack, stroke risk Amgen’s Repatha Cut Stroke, Heart Attack Risk (AMGN) Amgen cholesterol drug cuts heart attack, stroke risk but shares fall |
19
MAR
MAR
0